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Human cystatin C, a powerful physiological protein inhibitor of cathepsins B, H and L, contains two 
disulphide bridges, at least one of which is essential to its inhibitory activity. The positions of these bridges 
in the single polypeptide chain of the protein have been determined by diagonal paper electrophoresis. The 
cysteine residues at positions 73 and 83 form one bridge, and those at positions 97 and 117 form the other. 
In the homologous cystatin of chicken egg-white, the disulphides are Cys 71-Cys 81, and Cys 95-Cys 115. 
Cathepsin Cystatin Cystatin C Cysteine proteinase 
Proteinase inhibitor 
Plasma protein 
1. INTRODUCTION 
Cystatin C (previously called y-trace) is a tight- 
binding inhibitor of the lysosomal cysteine pro- 
teinases, cathepsins B, H and L; it occurs in human 
cells and extracellular fluids, and is thought to con- 
tribute to physiological control of the proteinases 
[l]. The amino acid sequences of the single 
polypeptide chains of human cystatin C and the 
homologous chicken cystatin have been deter- 
mined [2,3], but the disulphide bridges have not 
been assigned, and nothing is known of their con- 
tribution to the inhibitory activity of the proteins. 
2. EXPERIMENTAL 
2.1. Human cystatin C and chicken cystatin 
Cystatin C was isolated from the urine of a pa- 
tient with renal failure as in [4], and subjected to 
additional chromatography on Bio-Gel P-60 in 
0.5 M NH4HCO3 before being freeze-dried. The 
N-terminal amino acid sequence was that of the 
undegraded protein, SSPGKPPRLVGGPMD [5]. 
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Chicken cystatin was the mixed forms of the pro- 
tein from egg-white [6]. 
2.2. Inactivation of cystatin C by reduction 
Cystatin C (1.3 mg/ml) in 0.025 M Tris-HCl 
buffer (pH 8.1) was made 1 mM dithiothreitol and 
1 mM EDTA, and held at 25°C. Samples were 
removed after 0, 1, 2, 3 and 4 h for assay of in- 
hibitory activity against papain, as in [7]. The thiol 
groups generated by reduction of disulphide bonds 
were quantified by the Ellman reaction after block- 
ing of dithiothreitol with sodium arsenite [8]. 
2.3. Enzymatic digestion of cystatin C and 
chicken cystatin 
Five mg cystatin in 0.25 ml of 5% (v/v) formic 
acid was digested at 37°C for 16 h with 0.1 mg 
pepsin (Worthington), lyophilized, redissolved in 
0.25 ml of 0.2 M NH4HCOs and digested at 37°C 
for 5 h with 0.1 mg trypsin-TPCK (Worthington). 
2.4. Diagonal paper electrophoresis 
The enzyme-digested material was freeze-dried, 
redissolved in 0.05 ml water, streaked on What- 
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man 3MM paper at a loading of 1.7 mg/cm and 
subjected to high voltage electrophoresis in 
pyridine-acetic acid-water (1: 10: 190, by vol., 
pH 3.5) for 1.5 h at 50 V/cm. A strip 3 cm wide 
containing the separated peptides was cut out and 
used to prepared a diagonal fingerprint after per- 
formic acid oxidation exactly as described in [9]. 
The electrophoresis in the second dimension was 
for 4 h at 20 V/cm. The peptides were detected 
with fluorescamine as described [lo], and those ly- 
ing off the diagonal were eluted from the paper 
with 0.2 M NH40H and freeze-dried. 
2.5. Structural analysis 
The amino acid compositions of the peptides off 
the diagonal were determined with a Beckman 
119CL amino acid analyzer after hydrolysis in 6 M 
HCI at 110°C for 20 h in evacuated and sealed 
tubes. Liquid phase sequencer degradations were 
performed in a Beckman 890C instrument in the 
presence of polybrene [ 111. The phenylthiohydan- 
toin amino acid derivatives were identified by high 
performance liquid chromatography [121. 
3. RESULTS AND DISCUSSION 
Treatment of cystatin C with 1mM 
+ 
-- BEFORE OXRAllON 
dithiothreitol caused a loss of inhibitory activity in 
parallel with the reduction of disulphide bonds. 
After 4 h, 0.14 mM disulphide bonds had been 
reduced (0.19 mM maximum predicted for com- 
plete reduction), and inhibitory activity had fallen 
to 9%. In similar experiments, chicken cystatin has 
been found also to be inactivated by mild reduc- 
tion, although less rapidly than cystatin C 
(unpublished). 
Diagonal fingerprint analysis of the performic 
acid oxidized pepsin-trypsin digest of human 
cystatin C revealed 7 peptides lying off the 
diagonal in 3 groups (fig. la). The yields and amino 
acid compositions of these peptides are given in 
table 1. The amino acid compositions of the pep- 
tides identified them with a high degree of certain- 
ty in the known sequence (table 1). Moreover, se- 
quence analysis of the peptides confirmed their 
identities (table 2). The results allow us to conclude 
that human cystatin C contains two disulphide 
bridges. One is formed by cysteine residues 73 and 
83 and gives rise to the peptides 2a, 2b, 3a and 3b 
upon enzymatic digestion of the protein, and the 
other is formed by cysteine residues 97 and 117, 
and gives rise to the peptides la, lb and lc (fig.2a). 
For chicken cystatin, diagonal electrophoresis 
showed 4 peptides off the diagonal (fig.lb), and 
(b) 
3 
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Fig.1. Drawing of the diagonal peptide maps of performic acid oxidized pepsin-trypsin digests of: (a) native human 
cystatin C; (b) ovocystatin, showing the major (solid line) and minor (dotted line) fluorescamine-positive spots. 
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Table 1 
Amino acid composition of peptides with cysteic acid residues from a performic acid oxidized digest of native human 
cystatin C and of the corresponding segments of its intact polypeptide chain. Residue numbering according to [2] 
Peptide or polypeptide chain segment 
laa 95-101 lb” 95-100 lca 115-120 2aa 71-75 2b” 76-91 3a” 76-92 3b” 71-75 
CyS03H 0.5 1 0.8 1 0.8 1 0.7 1 0.9 1 0.8 1 0.9 1 
Asp 0.3 0.2 1.0 1 0.6 4.0 4 3.9 4 0.2 
Thr 0.4 0.2 1.0 1 2.5 3 1.5 1 0.9 1 2.8 3 
Ser 0.9 1 0.8 1 1.0 1 0.3 0.5 
Glu 1.1 1 1.2 1 1.0 1 0.5 2.2 2 2.0 2 0.1 
Pro 0.2 0.2 0.4 2.9 3 3.2 3 
Cly 0.4 0.4 0.1 0.3 0.6 
Ala 1.0 1 0.8 1 1.0 1 0.2 0.3 
Val 0.3 0.2 0.3 0.4 
Be 0.7 1 0.1 0.1 
Leu 0.2 0.4 i.8 2 2.0 2 
Phe 1.5 2 1.6 2 0.2 0.1 0.9 1 0.9 1 
Lys 1.0 1 0.3 0.9 1 1.0 1 
His 1.8 2 1.9 2 
Ar8 0.1 
Yield (nmol) 35 45 56 13 7 84 81 
‘. a Expressed as mol amino acid residues per mol peptide Figures below 0.1 are not reported 
Table 2 
Amino acid sequences of cysteic acid-containing 
peptides from human cystatin C 
Peptide Amino acid sequence 
la 
lc 
3a 
3b 
Ala-Phe-Xa-Ser-Phe-Gln-Ile 
Ser-Thr-Xa-Gln-Asp-Ala 
Thr-Gln-Pro-Asn-Leu-Asp-Asn-X”-Pro- 
Phe-His-Asp- 
Thr-Thr-Xa-Thr-Lys 
a The cysteic acid derivative is not extractable with butyl 
chloride 
amino acid analysis of these (table 3) unam- 
biguously located them in the sequence (fig.2b). As 
expected, they matched those in the homologous 
cystatin C. 
The exact reason for the dependence of activity 
of cystatin C on the disulphide loop(s) remains to 
be established. In many serine proteinase in- 
hibitors, including the soybean Kunitz inhibitor 
[ 131, the inhibitory site is within a disulphide loop 
that is essential for activity. This seems unlikely for 
cystatin C, however, since the homologous 
cystatins A and B do not contain the disulphide 
loops, but nevertheless are also strong inhibitors, 
and the portions of sequence within the disulphide 
loops are very poorly conserved between the three 
human cystatins [l]. More probably, the 
disulphides simply stabilize the native conforma- 
tions of cystatin C and chicken cystatin, as they do 
for many other extracellular proteins. Cystatins A 
and B are thought to be predominantly in- 
tracellular, and intracellular proteins generally do 
not contain disulphides, which might in any case 
be unstable in the reducing conditions of the 
cytosol. 
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10 20 30 40 50 60 
SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALOVVRARKDIVAGV 
6, 10 80 40 100 110 120 
NYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQlYAVPS~GTMTLSKSTCaDA 
1 I I I 
t3b-+<-33aw t-lb--+ +1c- 
t2a+‘2b-> -Ia+ 
10 20 30 40 50 60 
SEDRSRLLGAPVPVDENDEGLORALOFAMAEYNRASNDKYSSRVVRVISAKROLVSGIKY 
61 70 80 90 100 110 116 
I LQVEI GRTTCPKSSGDLQSCEFHD EPEMAKYTTCTFVVYS IPWLNQIKLLESKCQ 
1 I I I 
t2 a4 -2 b+ t1 a+ fl ta 
Fig.2. The disulphide bridges of human cystatin C (a) and ovocystatin (b), and the peptides used in their localization. 
The amino acid sequences are those of [2] and [3], respectively. 
Table 3 
Amino acid composition of cysteic acid-containing peptides from a 
performic acid oxidized digest of chicken cystatin, and of the corresponding 
segments of its intact polypeptide chain. Residue numbering according to [3] 
Peptide or polypeptide chain segment 
laa 93-96 lba 115-116 2aa 69-73 2ba 74-82 
CySO,H 1.0 1 
Asp 
Thr 2.8 3 
Ser 
Glu 0.1 
Pro 
Cly 0.1 
Val 
Leu 
T yr 0.3 
LYS 
Yield (nmol) 76 61 29 
0.8 1 0.9 1 
0.1 
1.9 2 
0.2 
1.0 1 0.2 
1.1 1 
0.2 
0.2 
0.2 
1.0 1 
0.8 
1.0 
2.4 
2.0 
1.0 
0.1 
1.0 
0.1 
47 
a Expressed as mol amino acid residue per mol peptide. Figures below 0.1 
are not reported 
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